Jocelyn Solis-Moreira

Jocelyn Solis-Moreira

Feature Writer

B.Sc. Integrative Neuroscience, M.Sc. Psychology

Jocelyn Solis-Moreira graduated with a Bachelor's in Integrative Neuroscience, where she then pursued graduate research looking at the long-term effects of adolescent binge drinking on the brain's neurochemistry in adulthood. She is adept at translating and summarizing complex study findings in all medical fields with a particular interest in neurodegenerative diseases, cancer research, infectious diseases, and public health. As a freelance writer, her work spans from news articles and feature articles to evergreen explainers across many publications. Her overall goal is to make science accessible for all.

Articles from Jocelyn

SARS-CoV-2 in wastewater may pose risks to marine mammals

SARS-CoV-2 in wastewater may pose risks to marine mammals

Study targets main protease of SARS-CoV-2 involved in viral replication

Study targets main protease of SARS-CoV-2 involved in viral replication

Study says air pollution played a role in early U.S. COVID-19 outbreak

Study says air pollution played a role in early U.S. COVID-19 outbreak

Structure and function of locked conformation of the SARS-CoV-2 spike protein identified

Structure and function of locked conformation of the SARS-CoV-2 spike protein identified

People previously infected with SARS-CoV-2 may achieve immunity after one mRNA vaccine dose, finds study

People previously infected with SARS-CoV-2 may achieve immunity after one mRNA vaccine dose, finds study

Study finds limited association between vitamin D and improved COVID-19 outcomes

Study finds limited association between vitamin D and improved COVID-19 outcomes

Single mRNA vaccine dose may be enough for those previously exposed to SARS-CoV-2

Single mRNA vaccine dose may be enough for those previously exposed to SARS-CoV-2

Neutralizing antibodies may be evolving to keep up with SARS-CoV-2 mutations

Neutralizing antibodies may be evolving to keep up with SARS-CoV-2 mutations

SARS-CoV-2's amyloid-driving nucleoprotein could inform future therapeutic research

SARS-CoV-2's amyloid-driving nucleoprotein could inform future therapeutic research

Greater cross-neutralization against UK SARS-CoV-2 variant in vaccinated individuals with prior infection

Greater cross-neutralization against UK SARS-CoV-2 variant in vaccinated individuals with prior infection